The involvement of PHDs in tumor development in many cases may appear paradoxical, because, while on the one hand there is evidence showing that PHDs can be detrimental for hypoxia adaptation and cancer progression, the use of PHD inhibitors leads to lower tumor growth and metastasis by diminishing immune tolerance and increasing tumor vessel normalization. This evidence concerns the gene PDC and neoplasm.